<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<meta name="Generator" content="Microsoft Word 14 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";
mso-fareast-language:EN-US;}
h1
{mso-style-link:"Heading 1 Char";
margin:0cm;
margin-bottom:.0001pt;
page-break-after:avoid;
font-size:12.0pt;
font-family:"Times New Roman","serif";
mso-fareast-language:EN-US;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
{mso-style-link:"Body Text Char";
margin:0cm;
margin-bottom:.0001pt;
text-align:justify;
text-autospace:none;
font-size:11.0pt;
font-family:"Tahoma","sans-serif";
color:black;
mso-fareast-language:EN-US;}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
{mso-style-link:"Body Text 2 Char";
margin:0cm;
margin-bottom:.0001pt;
text-align:justify;
font-size:10.0pt;
font-family:"Tahoma","sans-serif";
mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
{mso-style-priority:99;
mso-style-link:"Plain Text Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";
mso-fareast-language:EN-US;}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Tahoma","sans-serif";
color:windowtext;}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-link:"Heading 1";
font-family:"Times New Roman","serif";
font-weight:bold;}
span.BodyTextChar
{mso-style-name:"Body Text Char";
mso-style-link:"Body Text";
font-family:"Tahoma","sans-serif";
color:black;}
span.BodyText2Char
{mso-style-name:"Body Text 2 Char";
mso-style-link:"Body Text 2";
font-family:"Tahoma","sans-serif";}
span.PlainTextChar
{mso-style-name:"Plain Text Char";
mso-style-priority:99;
mso-style-link:"Plain Text";
font-family:"Calibri","sans-serif";}
p.Default, li.Default, div.Default
{mso-style-name:Default;
margin:0cm;
margin-bottom:.0001pt;
text-autospace:none;
font-size:12.0pt;
font-family:"Tahoma","sans-serif";
color:black;
mso-fareast-language:EN-US;}
p.GLPGBodyFinance, li.GLPGBodyFinance, div.GLPGBodyFinance
{mso-style-name:GLPG_BodyFinance;
mso-style-priority:99;
margin:0cm;
margin-bottom:.0001pt;
text-align:justify;
line-height:15.0pt;
text-autospace:none;
font-size:9.0pt;
font-family:"Tahoma","sans-serif";
color:black;
mso-fareast-language:EN-US;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri","sans-serif";
mso-fareast-language:EN-US;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:899948506;
mso-list-type:hybrid;
mso-list-template-ids:701380454 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:36.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-tab-stop:72.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level3
{mso-level-tab-stop:108.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level4
{mso-level-tab-stop:144.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level5
{mso-level-tab-stop:180.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level6
{mso-level-tab-stop:216.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level7
{mso-level-tab-stop:252.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level8
{mso-level-tab-stop:288.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level9
{mso-level-tab-stop:324.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-GB" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:9.0pt;font-family:"Tahoma","sans-serif"">Please find the vacancy at Galapagos for a Senior Scientist bioinformatician.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:9.0pt;font-family:"Tahoma","sans-serif""><o:p> </o:p></span></p>
<p class="GLPGBodyFinance"><span style="font-size:10.0pt">Galapagos is a mid-size, clinical stage biotechnology company active in discovery and development of small molecule and antibody therapies, many of which are based on proprietary disease-modifying drug
targets in disease areas for which there is a need for safe and effective medicines. Galapagos funds its research through alliance payments from its pharma partners, cash generated by its profitable service operations, licensing agreements, and its cash reserves.
GLPG0634, its most advanced program in Phase II, is partnered with AbbVie for up to $1.35 billion in milestones and double-digit royalties. Together with service operations BioFocus, Argenta and Fidelta, Galapagos’ research activities across Europe are successful
thanks to our highly motivated staff of more than 800 employees, a unique technology base, and a strong financial position.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal">For our site in Mechelen, we are looking for a <b><span style="font-family:"Tahoma","sans-serif""><o:p></o:p></span></b></p>
<h1 align="center" style="text-align:center"><span style="font-size:11.0pt;font-family:"Tahoma","sans-serif"">Senior Scientist Bioinformatics (m/f) full time MEC 115
<o:p></o:p></span></h1>
<p class="MsoNormal"><b><span style="font-family:"Tahoma","sans-serif""><o:p> </o:p></span></b></p>
<p class="MsoNormal"><b><span style="color:black">Job description<o:p></o:p></span></b></p>
<p class="Default" style="text-align:justify"><span style="font-size:10.0pt">As member of the Information Sciences group you will provide day to day bioinformatics support to research teams using dedicated bioinformatics software, in support of the various
target and drug discovery projects at Galapagos.<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span style="font-size:10.0pt">You will carry out target annotations: collecting, analyzing, storing and reporting assay, DNA and protein sequence, pathway, toxicity, druggability and related data,
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span style="font-size:10.0pt">You will support project teams in experiment design and in complex analysis of large data sets (eg. microarray data analysis).<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span style="font-size:10.0pt">You will collect bioinformatics-related end-user requirements and propose solutions. You will adapt or co-develop new bioinformatics applications and/or contribute to the implementation
of third-party software. You will support the research teams in optimally using these tools.<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span style="font-size:10.0pt">You will closely collaborate with multidisciplinary disease biology and drug discovery</span><span lang="EN-US" style="font-size:10.0pt"> teams, the Discovery Informatics group and
possible outsourcing partners. <o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt"><o:p> </o:p></span></p>
<p class="MsoPlainText"><b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black">Required skills and Experience:<o:p></o:p></span></b></p>
<p class="Default" style="margin-left:36.0pt;text-align:justify;text-indent:-18.0pt;mso-list:l0 level1 lfo1">
<![if !supportLists]><span style="font-size:10.0pt;font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="font-size:10.0pt">PhD in bioinformatics/biology/chemistry or equivalent through experience, with demonstrated track record in bioinformatics. 5 years of working experience, some of it in industry.
<o:p></o:p></span></p>
<p class="Default" style="margin-left:36.0pt;text-align:justify;text-indent:-18.0pt;mso-list:l0 level1 lfo1">
<![if !supportLists]><span style="font-size:10.0pt;font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="font-size:10.0pt">Good Bioinformatics skills (multiple sequence alignment, expression data analysis, pathway analysis, clustering, data and text mining, proteomics, etc.)
<o:p></o:p></span></p>
<p class="Default" style="margin-left:36.0pt;text-align:justify;text-indent:-18.0pt;mso-list:l0 level1 lfo1">
<![if !supportLists]><span style="font-size:10.0pt;font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="font-size:10.0pt">Good understanding of statistics and experimental design. Good knowledge of R or equivalent environment is a plus.<o:p></o:p></span></p>
<p class="Default" style="margin-left:36.0pt;text-align:justify;text-indent:-18.0pt;mso-list:l0 level1 lfo1">
<![if !supportLists]><span style="font-size:10.0pt;font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="font-size:10.0pt">Good scientific computing skills: programming expertise (e.g., in C#, Java, Perl or Python), database query experience (e.g., SQL) and a working knowledge of Linux are desirable. The aptitude and
zeal to acquire any of these skills are essential. <o:p></o:p></span></p>
<p class="MsoNormal" style="text-autospace:none"><span style="font-size:9.0pt;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:black">At Galapagos we aim to recruit the best people, who stand out among their peers, with integrity and exce</span>llent interpersonal and organizational skills. Our employees are the strength behind Galapagos, a
highly motivated team, eager to maintain Galapagos’ leading position and achieve breakthroughs in pharmaceutical research.
<o:p></o:p></p>
<p class="MsoBodyText2"><span lang="EN-US" style="font-size:11.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal">Do you have the qualifications for this job opening, and are you up to the challenge of joining our entrepreneurial team? If so, please send your application (preferably by e-mail) to:<o:p></o:p></p>
<p class="MsoBodyText"><span lang="EN-US" style="font-size:10.0pt">Galapagos NV - Human Resources<o:p></o:p></span></p>
<p class="MsoBodyText"><span style="font-size:10.0pt">Generaal De Wittelaan L11 A3<o:p></o:p></span></p>
<p class="MsoBodyText"><span lang="DE" style="font-size:10.0pt">B-2800 Mechelen, Belgium<o:p></o:p></span></p>
<p class="MsoBodyText"><span lang="DE" style="font-size:10.0pt">E-mail: </span><span lang="EN-US" style="font-size:10.0pt"><a href="mailto:jobs_be@glpg.com"><span lang="DE">jobs_be@glpg.com</span></a></span><span lang="EN-US" style="font-size:10.0pt;color:blue">
</span><span lang="DE" style="font-size:10.0pt"><o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:9.0pt;font-family:"Tahoma","sans-serif""><o:p> </o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<br><HR><BR>This e-mail and its attachment(s) (if any) may contain confidential and/or proprietary information and is intended for its addressee(s) only. Any unauthorized use of the information contained herein (including, but not limited to, alteration, reproduction, communication, distribution or any other form of dissemination) is strictly prohibited. If you are not the intended addressee, please notify the originator promptly and delete this e-mail and its attachment(s) (if any) subsequently.
Neither Galapagos nor any of its affiliates shall be liable for direct, special, indirect or consequential damages arising from alteration of the contents of this message (by a third party) or as a result of a virus being passed on.
<br></body>
</html>